Courage Against Cancer
Courage Against Cancer explores how ivermectin and mebendazole — two promising repurposed drugs — may enhance the effectiveness of standard cancer treatments. Learn how our ovarian cancer preclinical study aims to uncover synergistic potential that could redefine the future of integrative oncology.
In the face of a growing cancer crisis, the urgent need for alternative treatment options has become increasingly clear. This article examines the limitations of conventional therapies like chemotherapy and radiation and why embracing non-traditional treatments, such as those involving Ivermectin and Mebendazole, is crucial for enhancing patient outcomes and quality of life. By diversifying treatment options, we can provide hope to patients and families during their most challenging times.
In a landscape dominated by hype and headlines, our foundation is dedicated to a single, clear mission: moving the conversation about repurposed drugs like ivermectin and mebendazole from anecdote to evidence through rigorous, independent science.
Courage Against Cancer announces a new preclinical research initiative studying ivermectin and mebendazole against ovarian cancer. Learn what science currently shows about these repurposed antiparasitic drugs — and why this research may change the future of cancer therapy.
In recent years, two existing drugs—Ivermectin and Mebendazole—have captured the attention of researchers and healthcare professionals alike for their potential anti-cancer effects. As the quest for non-chemotherapy, non-radiation therapies advances, understanding how these drugs could reshape cancer treatment is becoming increasingly vital. This article delves into the science behind IVM and MBZ, illuminating their mechanisms, available research, and the promise they hold for the future of oncology.
A cancer diagnosis often focuses solely on the tumor. But what about the person fighting the battle? Discover how Integrative Oncology is revolutionizing cancer care by combining the best of conventional science with evidence-based complementary therapies to manage side effects, empower patients, and heal the whole person—not just the disease.
Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.
Explore the science behind using a ketogenic diet as a supportive metabolic therapy for cancer. This deep dive explains how nutritional ketosis may starve cancer cells by exploiting the Warburg Effect, suppress oncogenic signaling via insulin reduction, and exert potent epigenetic effects through ketone bodies. Learn about the evidence and essential precautions.
Exciting lab studies show berberine can fight cancer cells through multiple mechanisms. But is it a safe or effective treatment for humans? We break down the pre-clinical evidence, critical limitations, and why consulting your oncologist is the most important step you can take.
Feeling lost after a cancer diagnosis? Find your courage and take control. Explore conventional and non-conventional treatment options tailored to your specific cancer type and stage with our powerful database.
Courage Against Cancer 